Go Pro

Quantum-Si (NASDAQ:QSI) Shares Down 1.3% - What's Next?

Quantum-Si logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Quantum-Si shares fell 1.3% to approximately $0.75 on Wednesday, with trading volume down 45% from its average. The company has a market capitalization of about $164 million and a high beta of 3.25.
  • Analyst sentiment remains mixed, with one Buy, one Hold, and one Sell rating; the consensus rating is Hold with a $1.00 price target.
  • Quantum-Si reported a quarterly loss of $0.11 per share, in line with estimates, while revenue of $340,000 exceeded expectations. Institutional investors own 39.9% of the stock, and several firms recently initiated or increased positions.
  • Five stocks we like better than Quantum-Si.

Quantum-Si Incorporated (NASDAQ:QSI - Get Free Report)'s stock price traded down 1.3% on Wednesday . The stock traded as low as $0.7460 and last traded at $0.75. Approximately 1,441,517 shares changed hands during trading, a decline of 45% from the average daily volume of 2,631,122 shares. The stock had previously closed at $0.76.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Alliance Global Partners restated a "buy" rating on shares of Quantum-Si in a research report on Friday, August 14th. Weiss Ratings upgraded shares of Quantum-Si from a "sell (e+)" rating to a "sell (d-)" rating in a report on Tuesday, August 25th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $1.00.

Check Out Our Latest Research Report on QSI

Quantum-Si Price Performance

The business's 50-day moving average price is $0.80 and its two-hundred day moving average price is $0.89. The company has a market capitalization of $164.16 million, a P/E ratio of -1.63 and a beta of 3.25.

Quantum-Si (NASDAQ:QSI - Get Free Report) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.11) EPS for the quarter, meeting analysts' consensus estimates of ($0.11). The business had revenue of $0.34 million during the quarter, compared to analysts' expectations of $0.30 million. Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. Research analysts expect that Quantum-Si Incorporated will post -0.47 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Quantum-Si

Several large investors have recently modified their holdings of QSI. Prudential Financial Inc. bought a new position in shares of Quantum-Si during the 2nd quarter valued at about $25,000. Cerity Partners LLC bought a new stake in Quantum-Si during the 2nd quarter worth approximately $29,000. Leonteq Securities AG bought a new stake in Quantum-Si during the 4th quarter worth approximately $28,000. BNP Paribas Financial Markets raised its holdings in Quantum-Si by 101.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 30,464 shares of the company's stock worth $43,000 after buying an additional 15,331 shares during the period. Finally, IPG Investment Advisors LLC acquired a new stake in Quantum-Si during the 2nd quarter worth approximately $27,000. 39.90% of the stock is currently owned by institutional investors.

About Quantum-Si

(Get Free Report)

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Quantum-Si Right Now?

Before you consider Quantum-Si, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.

While Quantum-Si currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines